Literature DB >> 6733408

RBE values and repair characteristics for colo-rectal injury after caesium 137 gamma-ray and neutron irradiation. II. Fractionation up to ten doses.

N H Terry, J Denekamp.   

Abstract

Early and late colo-rectal damage in mice have been assessed after 137Cs gamma irradiation and 3 MeV neutrons given as 1,2,5 or 10 fractions. Damage was measured by early changes in body weight, the late production of short faecal pellets and the pattern of lethality after irradiation. The data have been analysed in terms of the time course of expression of damage, fractionation effects and the RBE for neutrons over a wide range of doses per fraction (0.5-12.5 Gy neutrons, 3.5-33.5 Gy gamma rays). An initial epithelial denudation led to an early loss of weight, maximal at 11-17 days after irradiation. A dose-dependent weight reduction persisted over the animals' life-time. Deaths after localised pelvic gamma irradiation were progressive with no sharp demarcation between early or late phases of injury. The time course for lethality was qualitatively similar after neutrons. Beyond six months the rectum became constricted by fibrosis and a higher proportion of small faecal pellets was observed. At 6-15 months relatively shallow dose-response curves were obtained for this change. The sparing effect of fractionation was marked for the gamma-irradiated mice and almost absent after neutrons. A very high repair increment (11 Gy) was seen with two gamma-ray fractions of 20 Gy. At lower doses per fraction the proportion of each gamma-ray fraction recovered was 50-69% for all assays, i.e., similar to that for other normal tissues. There was a slight enhancement in the sparing effect for the late compared with the early assays over the lower dose range. The RBE was strongly dependent on dose per fraction because of the lack of reparable damage after neutrons. The RBE for both early and late effects was 5.0 at a neutron dose per fraction of 1 Gy. Extrapolation of the RBE data to lower doses, using the linear quadratic model, predicts a higher RBE for late (7.4-12.7) than for early damage (5.7-8.5) if gamma-ray doses below 5 Gy are used.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6733408     DOI: 10.1259/0007-1285-57-679-617

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  8 in total

1.  Fast neutron relative biological effects and implications for charged particle therapy.

Authors:  B Jones; T S A Underwood; A Carabe-Fernandez; C Timlin; R G Dale
Journal:  Br J Radiol       Date:  2011-12       Impact factor: 3.039

Review 2.  The contribution of women to radiobiology: Marie Curie and beyond.

Authors:  Anna Gasinska
Journal:  Rep Pract Oncol Radiother       Date:  2015-12-29

3.  Estimation of α/β for late rectal toxicity based on RTOG 94-06.

Authors:  Susan L Tucker; Howard D Thames; Jeff M Michalski; Walter R Bosch; Radhe Mohan; Kathryn Winter; James D Cox; James A Purdy; Lei Dong
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-03-04       Impact factor: 7.038

4.  Early and late effects of irradiation on morphometry and residual strain of mouse rectum.

Authors:  Hans Gregersen; Lilli Lundby; Jens Overgaard
Journal:  Dig Dis Sci       Date:  2002-07       Impact factor: 3.199

5.  A phenomenological relative biological effectiveness (RBE) model for proton therapy based on all published in vitro cell survival data.

Authors:  Aimee L McNamara; Jan Schuemann; Harald Paganetti
Journal:  Phys Med Biol       Date:  2015-10-13       Impact factor: 3.609

6.  Radiosensitization In Vivo by Histone Deacetylase Inhibition with No Increase in Early Normal Tissue Radiation Toxicity.

Authors:  Blaz Groselj; Jia-Ling Ruan; Helen Scott; Jessica Gorrill; Judith Nicholson; Jacqueline Kelly; Selvakumar Anbalagan; James Thompson; Michael R L Stratford; Sarah J Jevons; Ester M Hammond; Cheryl L Scudamore; Martin Kerr; Anne E Kiltie
Journal:  Mol Cancer Ther       Date:  2017-08-24       Impact factor: 6.261

7.  Hyaluronic gel injection into the vesicovaginal septum for high-dose-rate brachytherapy of uterine cervical cancer: an effective approach for bladder dose reduction.

Authors:  Naoya Murakami; Satoshi Shima; Tairo Kashihara; Nikolaos Tselis; Tomoyasu Kato; Yoshiaki Takagawa; Koji Masui; Ken Yoshida; Kana Takahashi; Koji Inaba; Kae Okuma; Hiroshi Igaki; Yuko Nakayama; Jun Itami
Journal:  J Contemp Brachytherapy       Date:  2019-01-29

8.  The Organ Sparing Potential of Different Biological Optimization Strategies in Proton Therapy.

Authors:  Helge Henjum; Tordis J Dahle; Lars Fredrik Fjæra; Eivind Rørvik; Sara Pilskog; Camilla H Stokkevåg; Andrea Mairani; Kristian S Ytre-Hauge
Journal:  Adv Radiat Oncol       Date:  2021-08-17
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.